Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Apr 20;9(4):1181.
doi: 10.3390/jcm9041181.

Protein S for Portal Vein Thrombosis in Cirrhotic Patients Waiting for Liver Transplantation

Hao-Chien Hung  1 , Jin-Chiao Lee  1 , Chih-Hsien Cheng  1 , Yu-Chao Wang  1 , Tsung-Han Wu  1 , Chen-Fang Lee  1 , Ting-Jung Wu  1 , Hong-Shiue Chou  1 , Kun-Ming Chan  1 , Wei-Chen Lee  2
Affiliations

Protein S for Portal Vein Thrombosis in Cirrhotic Patients Waiting for Liver Transplantation

Hao-Chien Hung et al. J Clin Med. .

Abstract

Portal vein thrombus (PVT) is a challenge in liver transplantation. How PVT develops in cirrhotic patients who already have coagulopathy is unclear. This study aimed to investigate possible contributing factors to PVT in cirrhotic patients. A total of 349 cirrhotic patients who waited liver transplantation were included in this study and 48 of them had PVT. For all the patients, the mean age was 53.5 ± 9.0 year old, and 75.9% of the patients were male. There were 233 (66.8%) patients who had either hepatitis B or C. The mean Model For End-Stage Liver Disease (MELD) score was 16.4 ± 7.5. Eighteen of 48 patients with PVT and 145 of 301 patients without PVT received liver transplantation. Multivariate analysis showed that low protein S level (hazard ratio = 2.46, p = 0.017) was the only independent risk factor for PVT development. Protein S deficiency also demonstrated prognostic value on short-term survival, not only for cirrhotic patients awaiting liver transplantation (69.9% versus 84.1% at 1 year survival, p = 0.012), but also for the patients having liver transplantation (70.4% versus 84.8% at 1 year survival, p = 0.047). In conclusion, protein S level was an independent risk factor for PVT development in decompensated cirrhotic patients, and protein S deficiency was also a prognostic factor for the patients waiting for liver transplantation.

Keywords: cirrhosis; liver transplantation; portal vein thrombus; protein S.

PubMed Disclaimer

Conflict of interest statement

There is no conflict of interest among authors.

Figures

Figure 1
Figure 1
The Kaplan–Meier survival curve of the transplant recipients with or without PVT. The 1 year, 3 year and 5 year survival after transplantation for the patients with PVT were 90.3%, 71.0%, and 61.8%, compared with 86.1%, 76.2%, and 74.2% for the patients without PVT (p = 0.956).
Figure 2
Figure 2
The Kaplan–Meier survival curve of patients waiting for liver transplantation with protein S ≤ 60%. For all enlisted patients, the 6 month and 1 year overall survival for the patients with protein S ≤ 60% (n = 48) were 74.3% and 69.9%, compared with 88.1% (p = 0.008) and 84.1% (p = 0.012) for the patients with protein S > 60%, respectively.
Figure 3
Figure 3
The Kaplan–Meier survival curve of patients with liver transplantation and protein S ≤ 60%. For the patients with transplantation, the 6 month and 1 year overall survival for the patients with protein S ≤ 60% (n = 27) were 70.4% and 70.4%, compared with 89.4% (p = 0.006) and 84.8% (p = 0.047) for the patients with protein S > 60% (n = 136).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Garcia-Pagan J.C., Valla D.C. Portal vein thrombosis: A predictable milestone in cirrhosis? J. Hepatol. 2009;51:632–634. doi: 10.1016/j.jhep.2009.06.009. - DOI - PubMed
    1. Kinjo N., Kawanaka H., Akahoshi T., Matsumoto Y., Kamori M., Nagao Y., Hashimoto N., Uehara H., Tomikawa M., Shirabe K., et al. Portal vein thrombosis in liver cirrhosis. World J. Hepatol. 2014;6:64–71. doi: 10.4254/wjh.v6.i2.64. - DOI - PMC - PubMed
    1. Okuda K., Ohnishi K., Kimura K., Matsutani S., Sumida M., Goto N., Musha H., Takashi M., Suzuki N., Shinagawa T. Incidence of portal vein thrombosis in liver cirrhosis. An angiographic study in 708 patients. Gastroenterology. 1985;89:279–286. doi: 10.1016/0016-5085(85)90327-0. - DOI - PubMed
    1. Francoz C., Belghiti J., Vilgrain V., Sommacale D., Paradis V., Condat B., Denninger M.H., Sauvanet A., Valla D., Durand F. Splanchnic vein thrombosis in candidates for liver transplantation: Usefulness of screening and anticoagulation. Gut. 2005;54:691–697. doi: 10.1136/gut.2004.042796. - DOI - PMC - PubMed
    1. Yerdel M.A., Gunson B., Mirza D., Karayalçin K., Olliff S., Buckels J., Mayer D., McMaster P., Pirenne J. Portal vein thrombosis in adults undergoing liver transplantation: Risk factors, screening, management, and outcome. Transplantation. 2000;69:1873–1881. doi: 10.1097/00007890-200005150-00023. - DOI - PubMed

LinkOut - more resources